Food as Medicine: Nutritionists, Clinicians Disagree on Role of Chemopreventive Supplements

Call it a food fight: Nutritionists say a diet rich in fruits and vegetables reduces cancer incidence, but some clinicians say cancer can't be thwarted by food alone, that supplements make better chemopreventives. Both sides point to epidemiological data supporting their respective positions. Recently, papers that try to explain the biochemical mechanisms by which foods and some supplements work have only added to the complexity of the debate. Beta carotene has been a rallying point. The antio

Written byPaul Smaglik
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Call it a food fight: Nutritionists say a diet rich in fruits and vegetables reduces cancer incidence, but some clinicians say cancer can't be thwarted by food alone, that supplements make better chemopreventives. Both sides point to epidemiological data supporting their respective positions. Recently, papers that try to explain the biochemical mechanisms by which foods and some supplements work have only added to the complexity of the debate.

Beta carotene has been a rallying point. The antioxidant most often associated with carrots had been linked to reducing lung cancer rates.1 But over time, the picture became less clear. "There were some contradictory studies ... with beta carotene," comments Marvin Legator, professor of preventive medicine and community health at the University of Texas Medical School at Galveston. "On one hand, you had some indications that it did decrease ... cancer .... And on the other hand, you had studies with tobacco, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies